✦ LIBER ✦

Indication for CDKN2A Mutation Analysis in Familial Pancreatic Cancer-Families Without Melanomas

✍ Scribed by Femme Harinck; Irma Kluijt; Theo A. van Os; Nienke van der Stoep; Rogier Oldenburg; Anja Wagner; Cora M. Aalfs; Rolf H. Sijmons; Jan-Werner Poley; Ernst J. Kuipers; Paul Fockens; Marco J. Bruno

Book ID: 119432631
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 95 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(11)60784-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Indication for CDKN2A-mutation analysis

Indication for CDKN2A-mutation analysis in familial pancreatic cancer families without melanomas

✍ Harinck, F.; Kluijt, I.; van der Stoep, N.; Oldenburg, R. A.; Wagner, A.; Aalfs, 📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 107 KB

Familial melanoma, pancreatic cancer and

Familial melanoma, pancreatic cancer and germline CDKN2A mutations

✍ Alisa M. Goldstein 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

Germline CDKN2A mutations have been observed in approximately 20 percent of familial melanoma kindreds from North America, Europe and Australasia. There is also an increased risk of pancreatic cancer in a subset of families with mutations, however, the precise relationship between the CDKN2A gene an

CDKN2A mutations in melanoma families fr

CDKN2A mutations in melanoma families from Uruguay

✍ A.L. Borges; F. Cuéllar; J.A. Puig-Butillé; M. Scarone; L. Delgado; C. Badenas; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

Mutation analysis of the CDKN2A promoter

Mutation analysis of the CDKN2A promoter in Australian melanoma families

✍ Pamela M. Pollock; Mitchell S. Stark; Jane M. Palmer; Marilyn K. Walters; Joanne 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 1 views

## Abstract Approximately 50% of all melanoma families worldwide show linkage to 9p21‐22, but only about half of these have been shown to contain germ line __CDKN2A__ mutations. It has been hypothesized that a proportion of these families carry mutations in the noncoding regions of __CDKN2A.__ Seve

Mutation analysis of the CDKN2A promoter

Mutation analysis of the CDKN2A promoter in Australian melanoma families

✍ Pollock, Pamela. M.; Stark, Mitchell; Palmer, Jane M.; Walters, Marilyn K.; Mart 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 32 KB

Mutation screening of the CDKN2A promote

Mutation screening of the CDKN2A promoter in melanoma families

✍ Mark Harland; Elizabeth A. Holland; Paola Ghiorzo; Michela Mantelli; Giovanna Bi 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

Germline mutations of CDKN2A, at 9p21, are responsible for predisposition to melanoma in some families. However, evidence of linkage to 9p21 has been demonstrated in a significant proportion of kindreds with no detectable mutations in CDKN2A. It is possible that mutations in noncoding regions may be